FI875159A0 - Menetelmä terapeuttisesti käyttökelpoisten, /3S(Z)/-2-///1-(2-amino-4-tiatsolyyli)-2-//2,2-dimetyyli-4-okso-1-(sulfo-oksi)-3-atsetidinyyli/amino/-2-oksoetylideeni/amino/oksi/etikkahapon kiteisten dierytromysiini- ja dikoliinisuolojen valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten, /3S(Z)/-2-///1-(2-amino-4-tiatsolyyli)-2-//2,2-dimetyyli-4-okso-1-(sulfo-oksi)-3-atsetidinyyli/amino/-2-oksoetylideeni/amino/oksi/etikkahapon kiteisten dierytromysiini- ja dikoliinisuolojen valmistamiseksi

Info

Publication number
FI875159A0
FI875159A0 FI875159A FI875159A FI875159A0 FI 875159 A0 FI875159 A0 FI 875159A0 FI 875159 A FI875159 A FI 875159A FI 875159 A FI875159 A FI 875159A FI 875159 A0 FI875159 A0 FI 875159A0
Authority
FI
Finland
Prior art keywords
amino
preparation
dicoline
dierythromycin
oxoethylidene
Prior art date
Application number
FI875159A
Other languages
English (en)
Swedish (sv)
Other versions
FI875159A (fi
FI91757B (fi
FI91757C (fi
Inventor
William Lawrence Parker
Edward Morton Cohen
William Henry Koster
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of FI875159A0 publication Critical patent/FI875159A0/fi
Publication of FI875159A publication Critical patent/FI875159A/fi
Publication of FI91757B publication Critical patent/FI91757B/fi
Application granted granted Critical
Publication of FI91757C publication Critical patent/FI91757C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI875159A 1986-12-19 1987-11-23 Menetelmä terapeuttisesti käyttökelpoisten, /3S(Z)/-2-///1-(2-amino-4-tiatsolyyli)-2-//2,2-dimetyyli-4-okso-1-(sulfo-oksi)-3-atsetidinyyli/amino/-2-oksoetylideeni/amino/oksi/etikkahapon kiteisten dierytromysiini- ja dikoliinisuolojen valmistamiseksi FI91757C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/944,283 US4751220A (en) 1986-12-19 1986-12-19 Crystalline salts of [3S(Z)]-2[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy]acetic acid
US94428386 1986-12-19

Publications (4)

Publication Number Publication Date
FI875159A0 true FI875159A0 (fi) 1987-11-23
FI875159A FI875159A (fi) 1988-06-20
FI91757B FI91757B (fi) 1994-04-29
FI91757C FI91757C (fi) 1994-08-10

Family

ID=25481130

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875159A FI91757C (fi) 1986-12-19 1987-11-23 Menetelmä terapeuttisesti käyttökelpoisten, /3S(Z)/-2-///1-(2-amino-4-tiatsolyyli)-2-//2,2-dimetyyli-4-okso-1-(sulfo-oksi)-3-atsetidinyyli/amino/-2-oksoetylideeni/amino/oksi/etikkahapon kiteisten dierytromysiini- ja dikoliinisuolojen valmistamiseksi

Country Status (25)

Country Link
US (1) US4751220A (fi)
JP (1) JP2511083B2 (fi)
KR (1) KR960007534B1 (fi)
AU (1) AU600536B2 (fi)
BE (1) BE1000625A3 (fi)
CA (1) CA1296717C (fi)
CH (1) CH674009A5 (fi)
DE (1) DE3743111C2 (fi)
DK (1) DK671487A (fi)
ES (1) ES2007766A6 (fi)
FI (1) FI91757C (fi)
FR (1) FR2610627B1 (fi)
GB (1) GB2199033B (fi)
GR (1) GR871937B (fi)
HU (1) HU197568B (fi)
IE (1) IE61325B1 (fi)
IL (1) IL84521A (fi)
IT (1) IT1233457B (fi)
LU (1) LU87076A1 (fi)
NL (1) NL193639C (fi)
NZ (1) NZ222599A (fi)
PH (1) PH23170A (fi)
PT (1) PT86403B (fi)
SE (1) SE467782B (fi)
ZA (1) ZA879031B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
WO2003054155A2 (en) * 2001-12-19 2003-07-03 Bristol-Myers Squibb Company Pichia pastoris formate dehydrogenase and uses therefor
CN101724000B (zh) * 2008-10-29 2012-05-30 广东东阳光药业有限公司 一种红霉素的结晶方法
CN113754651B (zh) * 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法
CN115463219A (zh) * 2021-11-09 2022-12-13 中国医学科学院医药生物技术研究所 包含β-内酰胺类化合物的药物组合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES376380A1 (es) * 1970-01-30 1972-04-16 Roger Lab Procedimiento de obtencion de un nuevo derivado de eritro- micina.
AU8364875A (en) * 1974-08-21 1977-02-10 Hoffmann La Roche Choline and n-methyl-d-glucamine salts of amoxycillin
US4533660A (en) * 1980-10-31 1985-08-06 E. R. Squibb & Sons, Inc. Antibacterial O-sulfated β-lactam hydroxamic acids
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
US4638061A (en) * 1985-01-28 1987-01-20 E. R. Squibb & Sons, Inc. [3S(Z)]-2-[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy] acetic acid and intermediate

Also Published As

Publication number Publication date
IE61325B1 (en) 1994-11-02
FI875159A (fi) 1988-06-20
HUT45998A (en) 1988-09-28
NL193639C (nl) 2000-05-04
PH23170A (en) 1989-05-19
IT1233457B (it) 1992-04-02
ES2007766A6 (es) 1989-07-01
GB8727048D0 (en) 1987-12-23
GB2199033A (en) 1988-06-29
SE467782B (sv) 1992-09-14
LU87076A1 (fr) 1988-07-14
DE3743111C2 (de) 1996-04-04
CH674009A5 (fi) 1990-04-30
FR2610627B1 (fr) 1989-12-01
IL84521A (en) 1992-02-16
BE1000625A3 (fr) 1989-02-21
FR2610627A1 (fr) 1988-08-12
AU600536B2 (en) 1990-08-16
KR880007528A (ko) 1988-08-27
JP2511083B2 (ja) 1996-06-26
PT86403A (en) 1988-01-01
NL193639B (nl) 2000-01-03
GB2199033B (en) 1990-10-24
IL84521A0 (en) 1988-04-29
NZ222599A (en) 1989-09-27
FI91757B (fi) 1994-04-29
ZA879031B (fi) 1988-05-27
JPS63165381A (ja) 1988-07-08
CA1296717C (en) 1992-03-03
DK671487A (da) 1988-06-20
SE8705068D0 (sv) 1987-12-18
IE873447L (en) 1988-06-19
DK671487D0 (da) 1987-12-18
AU8185787A (en) 1988-06-23
KR960007534B1 (ko) 1996-06-05
FI91757C (fi) 1994-08-10
GR871937B (en) 1988-04-26
DE3743111A1 (de) 1988-06-30
US4751220A (en) 1988-06-14
SE8705068L (sv) 1988-06-20
HU197568B (en) 1989-04-28
PT86403B (pt) 1990-11-20
IT8722908A0 (it) 1987-12-07
NL8703047A (nl) 1988-07-18

Similar Documents

Publication Publication Date Title
GB8811645D0 (en) Novel 2-(5-fluoronicotinoyl)acetic acid derivative/salts thereof
FI88037B (fi) Foerfarande foer framstaellning av farmaceutiskt vaerdefullt kristallint (4r,5s,6s,8r,2's,4's)-3-/4-(2-dimetylaminokarbonyl)-pyrrolidinyltio/-4-metyl-6-(1-hydroxietyl)-1-azabicyklo-/3,2,0/-hept-2-en-7-on-2-karboxylsyratrihydrat
EP0197474A3 (en) Process for preparing optically active indoline-2-carboxylic acid
NO170330C (no) Fremgangsmaate for fremstilling av vesentlig optisk rent monohydrat av s-(-)-propyl-2',6'-pipekoloksylididhydroklorid
IL66286A (en) Crystalline beta form of(3s-(3alpha(z),4beta))-3-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)-acetyl)amino)-4-methyl-2-oxo-1-azetidinesulfonic acid and method for preparation thereof
CS666688A2 (en) Method of 7 beta-/2-(r)-2-phenyl-2-aminoacetamide)-3-chloro-3-(1-carbadethiacephem)-4-carboxylic acid's crystalline monohydrate form preparation
FI875159A (fi) Menetelmä terapeuttisesti käyttökelpoisten, /3S(Z)/-2-///1-(2-amino-4-tiatsolyyli)-2-//2,2-dimetyyli-4-okso-1-(sulfo-oksi)-3-atsetidinyyli/amino/-2-oksoetylideeni/amino/oksi/etikkahapon kiteisten dierytromysiini- ja dikoliinisuolojen valmistamiseksi
SE8600355L (sv) Forfarande for framstellning av 4,4-dialkyl-2-azetidinoner
NO165393C (no) Fremgansmaate for fremstilling av aryloksypropanolaminer og salter av disse med difenyleddiksyre.
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
NO174887C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aryl- alkyl-pyrrol-2-carboxylsyreforbindelser
CS647985A2 (en) Method of (z)-2-(2-amino-4-thiazolyl)-2-(esterified-carboxyimino)acetic acid's heterothioester production
IT1196480B (it) Processo per la preparazione di composti eterociclici azotati
AU3620089A (en) New process for the preparation of n-(23-vinblastinoyl) derivatives of 1-amino-methyl-phosphonic acid
CS666588A2 (en) Method of 7 beta-/2-(r)-2-(p-hydroxyphenyl)-2-aminoacetamido/-3-chloro-3-(carbadethiacephem)-4-carboxylic acid's crystalline monohydrate form preparation
YU106787A (en) Process for obtaining monohydrate of optically pure s-(-)-1-propyl-2',6'pipecoloxylidid chlorinehydrate
KR870017202U (ko) Vtr의 리일 구동 장치
KR870018947U (ko) Vtr의 테이프 리일 구동 장치
IT1170269B (it) Procedimento per preparare l'acido dl 2-(6'-metossi-2'-naftil)-propionico
NO174419C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive heterocykliske forbindelser

Legal Events

Date Code Title Description
BB Publication of examined application
BB Publication of examined application
MM Patent lapsed

Owner name: E.R. SQUIBB & SONS, INC.